During the concluding session of the two-day 4th Indo-U.S. Health Dialogue, India signed two important pacts with the U.S.
The first MoU was signed between the Health Ministry of India and the Department of Health and Human Services of the U.S. for cooperation in the field of Health and Biomedical Sciences. Another MoU was signed between Indian Council of Medical Research (ICMR) and the National Institute of Allergy and Infectious Diseases (NIAID) for cooperation with the International Center for Excellence in Research (ICER).
Issues related to strengthening of epidemiological research and surveillance, vaccine development, One Health, zoonotic and vector-borne diseases, health systems and health policies were discussed in the Dialogue.
India’s Federal Health Minister Mansukh Mandaviya said, “Important areas wherein both India and U.S. can work are managing health emergencies, supporting digital health and innovation, mental health interventions, research coupled with production related to diagnostics, therapeutics and vaccines.
“India supplies nearly all the developing world’s high-quality generic medicines. We are also the largest manufacturer of anti-TB drugs. Leveraging on this capability, we can supply affordable high-quality medication for patients the world over,” added Mandaviya.
Last updated: December 26th, 2025
